Greater Cannabis Company (GCAN) Total Debt (2016 - 2023)

Greater Cannabis Company's (GCAN) quarterly Total Debt came in at $36000.0 in Q3 2023, down 90.89% year-on-year from $395000.0 in Q3 2022, and down 86.15% quarter-over-quarter from $260000.0 in Q4 2022.

Greater Cannabis Company (GCAN) Total Debt (2016 - 2023) Analysis & Trends

Greater Cannabis Company's Total Debt history runs 8 years deep, the most recent figure standing at $36000.0 for Q3 2023.

  • On a quarterly basis, Total Debt fell 90.89% year-over-year to $36000.0 in Q3 2023; TTM through Sep 2023 was $36000.0, a 90.89% decrease from a year earlier, with the FY2022 full-year figure at $260000.0, changed 0.0% from the prior year.
  • Total Debt slipped to $36000.0 in Q3 2023 per GCAN's latest filing, from $260000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $585212.0 in Q4 2020 and bottomed at $36000.0 in Q3 2023.
  • The 5-year median for Total Debt is $282500.0 (2021), against an average of $328279.1.
  • Across the five-year window, Total Debt surged 2023.32% in 2019 and tumbled 90.89% in 2023, its largest moves.
  • Year by year, Total Debt stood at $260000.0 in 2019, then jumped by 125.08% to $585212.0 in 2020, then plunged by 55.57% to $260000.0 in 2021, then changed by 0.0% to $260000.0 in 2022, then slumped by 86.15% to $36000.0 in 2023.
  • Per Business Quant, the three latest GCAN Total Debt figures stand at $36000.0 (Q3 2023), $260000.0 (Q4 2022), and $395000.0 (Q3 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 11.45 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.63 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 28.76 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 7.15 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.34 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.81 Bn
10 Greater Cannabis Company 292,929.85 292,929.85 - -

Historic Data

Download Data
DateValue
Sep 30, 2023 36,000.00
Dec 31, 2022 260,000.00
Sep 30, 2022 395,000.00
Jun 30, 2022 285,000.00
Mar 31, 2022 260,000.00
Dec 31, 2021 260,000.00
Sep 30, 2021 571,050.00
Jun 30, 2021 282,500.00
Mar 31, 2021 282,500.00
Dec 31, 2020 585,212.00
Sep 30, 2020 571,050.00
Jun 30, 2020 327,082.00
Mar 31, 2020 425,350.00
Dec 31, 2019 260,000.00
Sep 30, 2019 260,000.00
Jun 30, 2019 260,000.00
Mar 31, 2019 260,000.00
Dec 31, 2018 260,000.00
Sep 30, 2018 260,000.00
Jun 30, 2018 19,299.00